跳至主要内容
临床试验/NCT03161509
NCT03161509终止4 期

Effect of Sleeve Gastroctomy on Pharmacokinetics of Paracetamol and Antiepileptic Drugs

Rambam Health Care Campus1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2017年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
2
试验地点
1
主要终点
Pharmacokinetic curve of paracetamol or antiepileptic drug: AUC

研究概览

简要总结

Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will measure pharmakokinetics of paracetamol and antiepileptic drugs before and 6 months after sleeve gastrectomy.

详细描述

Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will measure pharmakokinetics of paracetamol (in consenting subjects that are undergoing sleeve gastrectomy) and antiepileptic drugs (in consenting subjects that are chronically treated by a stable dose) before and 6 months after sleeve gastrectomy in 10 subjects.

Blood tests will be taken for drug levels before and 4-8 times after the subject takes the drug. A pharmacokinetic curve will be calculated and compared for each subject between prior to surgery and after surgery.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI over 30 and eligible for sleeve gastrectomy
  • Mentally capable for consent
  • (for the antiepileptic drug intervention) chronic stable treatment of antiepileptic drug

排除标准

  • Gastrointestinal illness impairing absorption
  • renal failure (glomerular filtration rate<45)
  • liver cirrhosis
  • heart failure (New York Heart Association class III or IV)

研究组 & 干预措施

paracetamol

Experimental

10 participants will undergo measurement of paracetamol levels before and after sleeve gastrectomy

干预措施: Paracetamol (Drug)

antiepileptic drug

Experimental

Up to 10 participants in each drug (up to 4 medications, total of up to 40 participants) will undergo measurement of levels of their chronic medication after a dose before and after sleeve gastrectomy

干预措施: Antiepileptic (either carbamazepine, lamotrigine, phenytoin or valproic acid) (Drug)

结局指标

主要结局

Pharmacokinetic curve of paracetamol or antiepileptic drug: AUC

时间窗: 8 hours

sequential measurement of paracetamol or antiepileptic drug (carbamazepine, lamotrigine, phenytoin or valproic acid), AUC

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Irit HOCHBERG MD

Principle investigator, Attending physician in Institute of Endocrinology, Diabetes and Metabolism

Rambam Health Care Campus

研究点 (1)

Loading locations...

相似试验